C12N2710/24162 - CPC Classification Index

ClassID:

110027 ⎘

C12N2710/24162 - CPC Classification

Classification description:

dsDNA viruses; Details; Poxviridae; Orthopoxvirus, e.g. vaccinia virus, variola; Methods of inactivation or attenuation by genetic engineering

Recent Application in this class:

20250302997

2025-10-02

IMPROVED VACCINIA VIRUS VECTORS

20230293608

2023-09-21

Oncolytic Vaccinia Virus

20230256057

2023-08-17

TREATMENT OF IMMUNE DEPRESSION

20220362316

2022-11-17

PHARMACEUTICAL COMPOSITION FOR TREATING CANCER COMPRISING ANTICANCER VIRUS, IMMUNE CHECKPOINT INHIBITOR AND HYDROXYUREA AS ACTIVE INGREDIENTS

20220347244

2022-11-03

RECOMBINANT VACCINIA VIRUS AND PHARMACEUTICAL COMPOSITION COMPRISING SAME

20220290179

2022-09-15

GENETICALLY ENGINEERED ONCOLYTIC VACCINIA VIRUSES AND METHODS OF USES THEREOF

20220275347

2022-09-01

ONCOLYTIC VACCINIA VIRUS

20200338149

2020-10-29

NOVEL GENETICALLY ENGINEERED VACCINIA VIRUSES

20200289592

2020-09-17

Genetically engineered vaccinia viruses

#10

20190336552

2019-11-07

GENETICALLY ENGINEERED VACCINIA VIRUSES

#11

20180195050

2018-07-12

Modified vaccinia virus strains for use in diagnostic and therapeutic methods

#12

20170340687

2017-11-30

Genetically engineered vaccinia viruses

#13

20170020938

2017-01-26

Oncolytic Vaccinia Virus

#14

20160281066

2016-09-29

Mitogen-activated protein kinase-dependent recombinant vaccinia virus (MD-RVV) and use thereof

#15

20150175976

2015-06-25

Modified vaccinia virus strains for use in diagnostic and therapeutic methods

#16

20140234257

2014-08-21

Oncolytic viruses and methods for treating neoplastic disorders

#17

20130251746

2013-09-26

Methods and compositions for poxvirus A35R protein

#18

20130183271

2013-07-18

Methods and compositions concerning poxviruses and cancer

#19

20120308995

2012-12-06

Vaccinia virus mutants containing the major genomic deletions of MVA

#20

20120294896

2012-11-22

Methods and Compositions for Poxvirus A35R Protein

#21

20120114612

2012-05-10

Oncolytic viruses and methods for treating neoplastic disorders

#22

20110293527

2011-12-01

Modified vaccinia virus strains for use in diagnostic and therapeutic methods

#23

20090155287

2009-06-18

Modified vaccinia virus strains for use in diagnostic and therapeutic methods

#24

20090155244

2009-06-18

Methods and compositions for poxvirus lacking A35R protein

#25

20090098529

2009-04-16

Methods for attenuating virus strains for diagnostic and therapeutic uses

#26

20090053244

2009-02-26

Modified vaccinia virus strains for use in diagnostic and therapeutic methods

#27

20090004723

2009-01-01

Methods and compositions concerning poxviruses and cancer

#28

20070036758

2007-02-15

Mutants of vaccinia virus as oncolytic agents

#29

20060216312

2006-09-28

Mutants of replication competent vaccinia virus

#30

20060099224

2006-05-11

Methods and compositions concerning poxviruses and cancer

#31

20050244430

2005-11-03

Orthopoxvirus vectors, genes and products thereof

#32

20050028226

2005-02-03

Vaccinia virus MVA-E3L-knockout-mutants and use thereof